Lymphedema Treatment Market is expected to reach US$ 11.58 Billion by 2028

PRESS RELEASE BY The Insight Partners 19 Jan 2022

Share this press on

Secondary Lymphedema Segment to Account for Maximum Market Share During 2021–2028


According to our latest study on “Lymphedema Treatment Market Size and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Condition Type, Treatment Type, and End-User,” the market is projected to reach US$ 11.58 billion by 2028 from US$ 8.15 billion in 2021; it is expected to grow at a CAGR of 5.1% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.       


Based on condition type, the lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment is projected to account for a larger market share during 2021–2028. Surging cases of disruption of the lymphatic systems owing to trauma result in a larger number of secondary lymphedema cases. In the US along with other countries, cancer treatment causes damage to the lymphatic system, thus favoring the growth of the lymphedema market.


By treatment type, the lymphedema treatment market is segmented into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. The market for the physiological procedure segment is further segmented as lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT).  The market for the debulking procedures segment is subsegmented into surgical debulking, liposuction, and others. The compression devices and bandaging segment held a considerable share of the market in 2021 and is likely to continue its dominance in the market during the forecast period.  Medi is engaged in offering compression garments for all individual needs. Circaid specializes in offering inelastic alternative compression garments that cater to the needs of patients suffering from venous and lymphatic disorders. They help not only in promoting self-management but also in maintaining patient compliance, providing them an improved quality­-of-life.


Majority of the hospitals and physicians are concerned with the treatment of lymphedema patients upon the onset of COVID-19 pandemic. The rechanneling of services by healthcare providers in 2020 severely affected the lymphedema patient group, as patients who needed to pay follow-up and rehabilitation visits at necessary intervals could not gain medical assistance unless necessary. This resulted in delayed treatments for both primary and secondary lymphedema patient groups, which hampered the quality of life among these patients.


BIOCOMPRESSION SYSTEMS,Tactile Medical, Smith and Nephew, BSN Medical GmbH,Lohmann & Rauscher GmbH & Co. KG, SIGVARIS GROUP, ThermoTek, Huntleigh Healthcare Limited, 3M,Mego Afek Ltd. are among the leading companies operating in the lymphedema treatment market.    

Lymphedema Treatment Market, by Region, 2021 (%)

Lymphedema Treatment Market, by Region, 2021 (%)

Lymphedema Treatment Market Size & Share, Growth by 2028

Download Free Sample

Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type {Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures [Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)], Debulking Procedures [Surgical Debulking, Liposuction, and Others], and Others}, and End-User (Hospitals, Clinics, Clinical Research Organizations, and Others)

Contact Us
Phone: +1-646-491-9876
Email Id:
Download Free PDF Brochure